基于临床照护计划理念的2型糖尿病药学监护实践

Pharmaceutical Care of Patients with Type 2 Diabetes Mellitus Based on CCPC Concept

目的探讨2型糖尿病(T2DM)治疗过程中加入基于临床照护计划(CCPC)的药学监护对疗效的影响。方法选取黄石市中心医院内分泌科2022年1月1日至3月31日收治的T2DM患者166例。按简单随机抽样法分为监护组和对照组,各83例。两组患者均予普通的医学诊断与治疗,监护组患者纳入CCPC中并加予药师参与的药学监护,内容包括,为患者建立个人档案,提供个体化用药宣教、用药指导、沟通交流等药学服务。结果治疗后,两组患者空腹血糖、餐后2 h血糖及体质量较治疗前均有所改善,且监护组各项指标改善幅度均明显大于对照组(P<0.05)。监护组患者用药依从率为96.39%,明显高于对照组的74.70%(χ2=18.728,P=0.000);监护组患者满意度为97.59%,明显高于对照组的66.27%(χ2=16.857,P=0.000)。结论T2DM治疗过程中加入基于CCPC药师参与的药学监护,有利于改善患者血糖及体质量,同时提高患者的满意度和用药依从性,从而进一步提高药学服务质量。

Objective To investigate the effect of pharmaceutical care based on clinical care program certification(CCPC)during the treatment of type 2 diabetes mellitus(T2DM).Methods A total of 166 patients with T2DM admitted to the Department of Endocrinology in the Huangshi Central Hospital from January 1 to March 31,2022 were selected and divided into the monitoring group and the control group by the simple random sampling method,with 83 cases in each group.The patients in the two groups were given normal medical diagnosis and treatment.On this basis,the patients in the monitoring group were included in CCPC for pharmaceutical care participated by pharmacists,the content included the establishment of personal files for patients,and the provision of pharmaceutical care such as individualized drug use education,drug use guidance and communication.Results After treatment,the fasting blood glucose,2 h postprandial blood glucose and body mass in the two groups were significantly better than those before treatment,and the improvement of each index in the monitoring group was significantly better than that in the control group(P<0.05).The medication compliance rate in the monitoring group was 96.39%,which was significantly higher than 74.70%in the control group(χ2=18.728,P=0.000).The patients'satisfaction in the monitoring group was 97.59%,which was significantly higher than 66.27%in the control group(χ2=16.857,P=0.000).Conclusion Pharmacists'participation in the pharmaceutical care based on CCPC during the treatment of T2DM is conducive to improving the blood glucose and body mass of patients,as well as improving patients'satisfaction and medication compliance,so as to further improve the quality of pharmaceutical care.